Brent crude oil prices spike to $70-$75 per barrel after the Trump administration stops waiving economic sanctions on Iran.

Jacob Miramar

2019-05-13 12:38:00 Mon ET

Brent crude oil prices spike to $70-$75 per barrel after the Trump administration stops waiving economic sanctions on Iranian oil exports. U.S. State Secretary Mike Pompeo announces that the U.S. no longer grants the core waivers to China, India, Japan, South Korea, and Turkey etc as of May 2019. This strategic move threatens to wipe off almost $1 million barrels of international crude oil per day. In response, oil prices surge to their highest levels since November 2018. Middle East countries such as Saudi Arabia and United Arab Emirates agree to make up for lost oil supply from Iran. Key oil price gyrations are likely to continue in 2019-2020, and crude oil futures forecast the upper range of $80-$95 per barrel. Oil price hikes can translate into higher profit margins for OPEC countries, especially Saudi Arabia and United Arab Emirates.

This upward oil price trend improves the economic prospects of Saudi Aramco in the next biggest IPO lock-up period. In the grand scheme, the American national security strategists trade off temporary oil price fluctuations with more draconian economic sanctions on the nuclear nation Iran. This containment strategy helps successfully isolate Iran to the detriment of oil-dependent economies worldwide.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More
The Trump team blocks Broadcom's bid for Qualcomm due to national security concerns and 5G telecom network issues.
James Campbell

2018-03-06 11:35:00 Tuesday ET

The Trump team blocks Broadcom's bid for Qualcomm due to national security concerns and 5G telecom network issues.

The Trump team blocks Broadcom's bid for Qualcomm due to national economic security concerns and 5G telecom network issues. Broadcom makes microchips fo

+See More
Apple settles its 2-year intellectual property lawsuit with Qualcomm by agreeing to a multi-year patent license.
Charlene Vos

2019-05-01 09:27:00 Wednesday ET

Apple settles its 2-year intellectual property lawsuit with Qualcomm by agreeing to a multi-year patent license.

Apple settles its 2-year intellectual property lawsuit with Qualcomm by agreeing to a multi-year patent license with royalty payments to the microchip maker

+See More
President Trump is open to extending the March 2019 deadline for raising tariffs on Chinese imports.
Peter Prince

2019-02-15 11:33:00 Friday ET

President Trump is open to extending the March 2019 deadline for raising tariffs on Chinese imports.

President Trump is open to extending the March 2019 deadline for raising tariffs on Chinese imports if both sides are close to mutual agreement. These bilat

+See More
Agile lean enterprises break down organizational silos to promote smart collaboration for better profitability and customer loyalty.
Laura Hermes

2020-11-03 08:30:00 Tuesday ET

Agile lean enterprises break down organizational silos to promote smart collaboration for better profitability and customer loyalty.

Agile lean enterprises break down organizational silos to promote smart collaboration for better profitability and customer loyalty. Heidi Gardner (2017

+See More
Sirius XM pays $3.5 billion shares to acquire the music app company Pandora.
Jonah Whanau

2018-09-25 10:35:00 Tuesday ET

Sirius XM pays $3.5 billion shares to acquire the music app company Pandora.

Sirius XM pays $3.5 billion shares to acquire the music app company Pandora. This acquisition would form the largest audio entertainment company worldwide.

+See More
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.
Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More